Aquestive Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $84.6M | $78.5M | $49.3M |
| FY2020 | $111.4M | $62.9M | $31.8M |
| FY2021 | $144.1M | $62.0M | $28.0M |
| FY2022 | $175.6M | $57.1M | $27.3M |
| FY2023 | $163.9M | $57.4M | $23.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $84.6M | $78.5M | $49.3M |
| FY2020 | $111.4M | $62.9M | $31.8M |
| FY2021 | $144.1M | $62.0M | $28.0M |
| FY2022 | $175.6M | $57.1M | $27.3M |
| FY2023 | $163.9M | $57.4M | $23.9M |